Abstract Objectives The clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis (AS) and concomitant active
Transcatheter heart valves technologies
Transcatheter heart valves technologies
Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension
Abstract Aims To evaluate the impact of neutrophil-to-lymphocyte ratio (NLR) on periprocedural pulmonary hypertension (PH) and 3-month all-cause mortality in
Transcatheter heart valves technologies
Impact of prosthesis oversizing on clinical outcomes of transcatheter aortic valve implantation using a self-expandable Evolut R valve
Abstract Background Transcatheter Aortic Valve Implantation (TAVI) has a growing target population after being indicated even in low-surgical-risk patients with
Transcatheter heart valves technologies
Female showed favorable left ventricle hypertrophy regression during post‐TAVR follow‐up
Abstract Transcatheter aortic valve replacement (TAVR) is a well‐established procedure using a catheter‐introduced valve prosthesis for patients with severe aortic
Transcatheter heart valves technologies
Mean compression ratio of a self-expandable valve is associated with the need for pacemaker implantation after transcatheter aortic valve replacement
Abstract Background The risk and timing of permanent pacemaker implantation (PPMI) after transcatheter aortic valve replacement (TAVR) is still hard
Transcatheter heart valves technologies
Transcatheter pulmonary valve replacement in surgically‐created double‐barrel right ventricular outflow tracts: A single center case‐series
Abstract This manuscript describes the feasibility and approach to the assessment and performance of transcatheter pulmonary valve replacement (tPVR) in
Transcatheter heart valves technologies
Transcatheter aortic valve replacement in patients with a pre-existing prosthetic mitral valve: a single center experience with two cases
Abstract Background The performance of transcatheter aortic valve replacement (TAVR) in patients with pre-existing prosthetic mitral valves is technically challenging
Transcatheter heart valves technologies
Percutaneous coronary intervention: Before, after, or during TAVR?
Abstract Key points Decisions surrounding if, and when, to perform coronary revascularization in patients undergoing trans‐catheter aortic valve replacement (TAVR)
